| Financial Year |
March 31 2023 |
| Monetary Funds |
2,486,210.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
24,935,630.11 |
| Advances to Suppliers |
3,066,294.84 |
| Other Receivables |
4,954,971.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,043,431,403.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,493.59 |
| Total Current Assets |
4,078,876,004.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,999,177.12 |
| Fixed Assetes |
101,840,629.15 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,461,528.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
186,545.66 |
| Deferred Income Tax Assets |
13,839,447.87 |
| Other Non-Current Assets |
20,250,592.66 |
| Sub-Total of Non-Current Assets |
182,577,921.25 |
| Total Assets |
4,261,453,925.84 |
| Short-Term Loans |
40,009,702.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
315,332,233.73 |
| Accounts Received In Advance |
18,149,538.86 |
| Employee Compensation Payable |
779,208.00 |
| Taxes Payable |
3,729,533.01 |
| Interest Payable |
35,445,872.22 |
| Dividend Payable |
-- |
| Other payables |
56,800,631.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
303,364,387.09 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
738,190,502.60 |
| Long-term Loans |
326,150,000.00 |
| Bonds Payable |
318,872,749.86 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
675,242,577.67 |
| Total Liabilities |
1,413,433,080.27 |
| Paid-In Capital(Or Share Stock) |
824,791,293.00 |
| Capital Surplus |
31,993,712.18 |
| Surplus Reserve |
196,783,187.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,794,452,653.37 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,848,020,845.57 |
| Owner's Equity（Stockholder's Equity） |
2,848,020,845.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,261,453,925.84 |
